Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275557 · ClinicalTrials.gov registry record
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
A clinical trial of Pancreatic Cancer and Pancreatic Cyst, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Recruiting
- Registry status
- 1,174
- Enrollment target
- 3
- Study locations
NCT04275557 is a study of Pancreatic Cancer and Pancreatic Cyst that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 1,174 participants, above the 389-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (202% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT04275557, a study of Pancreatic Cancer and Pancreatic Cyst, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- RECRUITING
- Registry status
- 1,174 participants
- Enrollment target
- 3
- Study locations
Study Summary
The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a large database of information obtained from blood, tissue, medical images, surveys and information from routine care to develop noninvasive diagnostic approaches that could be used as decision-making tools to effectively personalize clinical care.
Conditions Studied
Interventions
- OTHER Data collection
- OTHER Blood Sample collection
- OTHER Tissue sample collection
Study Locations (3)
Florida
- Florida Research Institute (FRI) - Lakewood Rch
- Sylvester Comprehensive Cancer Center & Jackson Memorial Hospital - Miami
- Moffitt Cancer Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,174 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04275557
The ClinicalTrials.gov registry entry for NCT04275557 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,174 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 389-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (202% higher). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Data collection is the first listed.
NCT04275557 reports 3 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04275557 about?
NCT04275557 is a clinical study titled "Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas". The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, cancer, or pancreatitis and are undergoing diagnosis and treatment at a participating institution. The goals of this project are to build a lar...
What is the current status of trial NCT04275557?
This trial is currently recruiting. The enrollment target is 1,174 participants. The study started on 2020-02-18. Estimated completion is 2027-06.
What conditions does trial NCT04275557 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Pancreatic Cyst.
What interventions are being tested in trial NCT04275557?
The interventions under investigation include: Data collection (OTHER), Blood Sample collection (OTHER), Tissue sample collection (OTHER).
Who is sponsoring clinical trial NCT04275557?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04275557 being conducted?
This trial has 3 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
RECRUITING · Phase 1
-
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
RECRUITING · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.